Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

182 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Whole-Exome Sequencing of Vitiligo Lesions Indicates Lower Burden of Somatic Variations: Implications in Risk for Nonmelanoma Skin Cancers.
Gupta I, Shankrit S, Narta K, Ghazi M, Grover R, Pandey R, Kar HK, Menon SM, Gupta A, Yenamandra VK, Singh A, Mukerji M, Mukhopadhyay A, Rani R, Gokhale RS, Dash D, Natarajan VT. Gupta I, et al. Among authors: ghazi m. J Invest Dermatol. 2023 Jun;143(6):1111-1114.e8. doi: 10.1016/j.jid.2022.11.018. Epub 2022 Dec 17. J Invest Dermatol. 2023. PMID: 36535361 Free article. No abstract available.
Baseline cell proliferation rates and response to UV differ in lymphoblastoid cell lines derived from healthy individuals of extreme constitution types.
Chakraborty S, Singhmar S, Singh D, Maulik M, Patil R, Agrawal SK, Mishra A, Ghazi M, Vats A, Natarajan VT, Juvekar S, Prasher B, Mukerji M. Chakraborty S, et al. Among authors: ghazi m. Cell Cycle. 2021 May;20(9):903-913. doi: 10.1080/15384101.2021.1909884. Epub 2021 Apr 18. Cell Cycle. 2021. PMID: 33870855 Free PMC article.
Comparison of the Efficacy of Povidone-Iodine with Mupirocin in Decolo-nizing Staphylococcus aureus from the Nasal Cavity of Healthcare Work-ers: A Single-Blinded Randomized Controlled Trial.
Abolghasemi S, Ghazi M, Ziaie S, Mahboubi A, Gachkar L, Keyvanfar A, Naeimipoor M. Abolghasemi S, et al. Among authors: ghazi m. Infect Disord Drug Targets. 2024 Sep 20. doi: 10.2174/0118715265301671240910070901. Online ahead of print. Infect Disord Drug Targets. 2024. PMID: 39313892 Clinical Trial.
182 results